Clinical trial recruitment specialist Trialbee has secured a majority investment from Varsity Healthcare Partners, a deal ...
Inovalon, a leading provider of data and solutions empowering data-driven healthcare, today announced the launch of Clinical Trial Eligibility Screener™, a new service designed to help sponsors, sites ...
The market presents opportunities in expanding recruitment technologies and AI-driven solutions, emphasizing patient ...
Clinical Trials Arena on MSN
Trialbee secures VHP investment to boost clinical trial recruitment
The funding will enable further international expansion, as well as development of the company’s Omnichannel partner ...
Aided by AI and better EHRs, healthcare leaders are integrating clinical trial recruitment into care management and coordination. Advances in pharmaceutical research and personalized medicine are ...
Please provide your email address to receive an email when new articles are posted on . GPT-4 was more accurate than GPT-3.5 in identifying patients but had longer load times and higher costs. The ...
NEW YORK--(BUSINESS WIRE)--Massive Bio, a cutting-edge AI driven clinical trial matching platform provider, and Foundation Medicine, Inc. today announced a strategic collaboration to increase patient ...
Modern clinical trials face an enrollment challenge. Over 80 percent of clinical trials conducted in the United States fail to meet their recruitment timelines, contributing to delays in therapeutic ...
The Preston Robert Tisch Brain Tumor Center grants first IRB approval for APTN-101’s Phase I clinical trial, enabling patient recruitment to ...
Growth supported by increasing biopharmaceutical innovation, decentralized trial models, and expanding global patient recruitment.Austin, Texas, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Clinical Trials ...
Merck's CEO Rob Davis emphasizes DEI as a strategic imperative, aligning it with scientific rigor and innovation, showcasing ...
HealthDay News — The rate of early termination or withdrawal in head and neck squamous cell carcinoma (HNSCC) clinical trials (CTs) has increased since 2000, with strategic decisions and poor ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results